- Short Communication
- Open Access
Platelet-activating factor changes in phospholipid extracts from the plasma, peripheral blood mononuclear cells and bone marrow mononuclear cells of patients with acute leukemia — A 31P MRS in vitro study
Cellular & Molecular Biology Letters volume 13, pages58–66(2008)
The aim of this investigation was to evaluate the changes in PAF concentrations in the plasma, PBMC and BMMC of patients with acute lymphoblastic leukemia (ALL) and acute myeloblastic leukemia (AML). The plasma was from 23 healthy volunteers (HV) and 44 patients with AL (16 ALL, 28 AML). The PBMC were from 15 HV and 55 patients with AL (18 ALL, 37 AML), and the BMMC from 40 patients with AL (11 ALL, 29 AML). Methanol-chloroform phospholipid extraction from 60 × 106 cells (PBMC or BMMC) was performed according to a modified version of Folch’s method. 31P MRS data was obtained on an AMX 300 Bruker spectrometer (7.05 T). The PAF concentration in the plasma of the patients with ALL or AML was lower than that for the healthy volunteers. The PAF concentration in the plasma of the patients with ALL did not differ significantly from that of the patients with AML. In the case of both the PBMC and BMMC, the PAF concentration was significantly diminished in patients with ALL relative to the concentration for those with AML and for the healthy volunteers. No differences were observed in the PAF concentrations for the AML patients and the healthy volunteers.
acute lymphoblastic leukemia
acute myeloblastic leukemia
bone marrow mononuclear cells
magnetic resonance spectroscopy
- PAF (CPLAS):
platelet-activating factor, 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine
peripheral blood mononuclear cells
Mazer, B.D., Sawami, H., Franklin, R. and Gelfand E.W. B-cell activation and regulation of immunoglobulin synthesis by platelet activating factor. Neth. J. Med. 39 (1991) 224–253.
Rola Pleszczynski, M., Pouliot, C., Turcotte, S., Pignol, B., Braquet, P. and Bouvrette, L. Immune regulation by platelet-activating factor: I. induction of supressor cell activity in human monocytes and CD8+ T cells and of helper cell activity in CD4+ T cells. J. Immunol. 140 (1988) 3547–3552.
Demopoulos, C.A., Pinckard, R.N. and Hanahan, D.J. Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators). J. Biol. Chem. 254 (1979) 9355–9358.
Blank, M.L., Snyder, F., Byers, L.W., Brooks, B. and Muirhead, E.E. Antihypertensive activity of an alkyl ether analog of phosphatidylcholine. Biochem. Biophys. Res. Commun. 90 (1979) 1194–1200.
O’Flaherty, J.T., Miller, C.H., Lewis, J.C., Wykle, R.L., Bass, D.A., McCall, C.E., Waite, M. and De Chatelet, L.R. Neutrophil responses to platelet-activating factor. Inflammation 5 (1981) 193–201.
Prpic, V., Uhing, R.J., Weiel, J.E., Jakoi, L., Gawdi, G., Herman, B. and Adams, D.O. Biochemical and functional responses stimulated by platelet-activating factor in murine peritoneal macrophages. J. Cell. Biol. 107 (1988) 363–372.
Chignard, M., Le Couedic, J.P., Tence, M., Vargftig, B.B. and Benveniste, J. The role of platelet-activating factor in platelet aggregation. Nature 279 (1979) 799–800.
Mc Intyre, T.M., Zimmerman, G.A. and Prescott, S.M. Leukotrienes C4 and D4 stimulate human endothelial cells to synthesize platelet-activating factor and bind neutrophils. Proc. Natl. Acad. Sc. USA 83 (1986) 2204–2208.
Jackson, R.J., Bolognese, B., Mangar, C.A., Hubbard, W.C., Marshall, L.A. and Winkler, J.D. The role of platelet-activating factor and other lipid mediators in inflammatory angiogenesis. Biochim. Biophys. Acta 1392 (1998) 145–152.
Kuliszkiewicz-Janus, M., Tuz, M.A. and Baczynski, S. Application of 31P MRS to the analysis of phospholipid changes in plasma of patients with acute leukemia. Biochim. Biophys. Acta 1737 (2005) 11–15.
Tuz, M.A., Kuliszkiewicz-Janus, M. and Baczynski, S. Application of 31P magnetic resonance spectroscopy to observation of phospholipid concentration changes in blood serum, plasma, peripheral blood mononuclear cells and bone marrow mononuclear cells from patients with hematological cancers — methodological review. Polish J. Chem. 80 (2006) 1009–1019.
Kuliszkiewicz-Janus, M., Tuz, M.A., Baczynski, S., Prajs, I. and Jaźwiec, B. 31P MRS analysis of the phospholipid composition of normal human peripheral blood mononuclear cells (PBMC). Cell. Mol. Biol. Lett. 10 (2005) 373–382.
Folch, J., Lees, M. and Sloan-Stanley, G.H. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226 (1957) 497–509.
Bradamante, S., Barchiesi, E., Barenghi, L. and Zoppi, F. An alternative expeditious analysis of phospholipid composition in human blood plasma by 31P NMR spectroscopy. Anal. Biochem. 185 (1990) 299–303.
Denizot, Y., Dupuis, F., Trimoreau, F., Praloran, V. and Liozon, E. Decreased levels of platelet-activating factor in blood of patients with lymphoid and non-lymphoid hematologic malignancies. Blood 85 (1995) 2992–2993.
Denizot, Y., Guglielmi, L., Donnard, M. and Trimoreau, F. Platelet-activating factor and normal or leukaemic haematopoiesis. Leuk. Lymphoma 44 (2003) 775–782.
Denizot, Y., Trimoreau, F., Dupuis, F., Verger, C. and Praloran, V. PAF and haematopoiesis: III. Presence and metabolism of platelet-activating factor in human bone marrow. Biochim. Biophys. Acta 1265 (1995) 55–60.
Dupuis, F., Rougier, F., Trimoreau, F., Ostyn, E., Dulery, C., Praloran, V. and Denizot, Y. Production and metabolism of platelet-activating factor by human bone marrow cells. Res. Immunol. 148 (1997) 119–126.
Donnard, M., Guglielmi, L., Turlure, P., Piguet, C., Couraud, M.J., Bordessoule, D. and Denizot, Y. Membrane and intracellular platelet-activating factor receptor expression in leukemic blasts of patients with acute myeloid and lymphoid leukemia. Stem. Cells 20 (2002) 394–104.
Berdel, W.E., Kulimova, E., Kolkmeyer, A., Zuhlsdorf, M., Serve, H., Buchner, T. and Oelmann, E. Receptor for platelet-activating factor (PAF) is not detectable by flow cytometry on the surface of myeloid leukemic cells. Ann. Hematol. 84 (2005) 771–773.
Garcia, M., Garcia, C., Gijon, M.A., Fernandez-Gallardo, S., Mollinedo, F. and Sanchez Crespo, M. Metabolism of platelet-activating factor in human haematopoietic cell lines. Biochem. J. 273 (1991) 573–578.
Trimoreau, F., Guglielmi, L., Touati, M., Faucher, J.L., Bordessoule, D. and Denizot, Y. Platelet-activating factor receptors on B cells of chronic lymphocytic leukaemia patients. British J. Haematol. 115 (2001) 711–712.
Guglielmi, L., Trimoreau, F., Donnard, M., Jaccard, A., Bordessoule, D. and Denizot, Y. Presence of membrane platelet-activating factor receptors on B cells of chronic B cell leukaemia patients. Leuk. Lymphoma 44 (2003) 1087–1088.
Foa, R., Bussolino, F., Ferrando, M.L., Guarini, A., Tetta, C., Mazzone, R., Gugliotta, L. and Camussi, G. Release of platelet-activating factor in human leukemia. Cancer Res. 45 (1985) 4483–4485.
Reynaud, S., Malissein, E., Donnard, M., Bordessoule, D., Turlure, P., Trimoreau, F. and Denizot, Y. Functional platelet-activating factor receptors in immature forms of leukemic blasts. Leuk. Res. 31 (2007) 399–402.
About this article
Cite this article
Kuliszkiewicz-Janus, M., Tuz, M.A., Kiełbiński, M. et al. Platelet-activating factor changes in phospholipid extracts from the plasma, peripheral blood mononuclear cells and bone marrow mononuclear cells of patients with acute leukemia — A 31P MRS in vitro study. Cell Mol Biol Lett 13, 58–66 (2008). https://doi.org/10.2478/s11658-007-0035-9
- Acute leukemia
- 31P MRS in vitro